Villar Conde S, Astillero López V, Gonzalez Rodriguez M, Villanueva Anguita P, Saiz Sanchez D, Martinez Marcos A, et al. The Human Hippocampus in Parkinson's Disease: An Integrative Stereological and Proteomic Study. J Parkinsons Dis. 2021;11:1345-1365 pubmed publisher

van der Zee J, Gijselinck I, Van Mossevelde S, Perrone F, Dillen L, Heeman B, et al. TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Hum Mutat. 2017;38:297-309 pubmed publisher

Gelpi E, Hoftberger R, Graus F, Ling H, Holton J, Dawson T, et al. Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol. 2016;132:531-43 pubmed publisher

Whitfield D, Vallortigara J, Alghamdi A, Howlett D, Hortobagyi T, Johnson M, et al. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment. Neurobiol Aging. 2014;35:2836-2844 pubmed publisher

Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, et al. Accumulation of ?-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol. 2014;127:235-41 pubmed publisher

Nimmo J, Verma A, Dodart J, Wang C, Savistchenko J, Melki R, et al. Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy. Alzheimers Res Ther. 2020;12:159 pubmed publisher

Erro Aguirre M, Zelaya M, Sánchez Ruiz de Gordoa J, Tuñón M, Lanciego J. Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsy. Front Neuroanat. 2015;9:25 pubmed publisher